TP53 and fibrosarcoma: Overall, our data demonstrate that stathmin absence does not influence the onset of bladder and skin carcinomas or fibrosarcomas in mice, suggesting that stathmin is dispensable for initiation of p53- and Ras-dependent tumors in mice.